News & Updates

In healthy individuals with functional constipation, probiotics supplementation does not appear to increase bowel movement frequency as compared with placebo, according to a study.

Retifanlimab takes the stage in POD1UM-303/InterAACT 2, a trial showing encouraging efficacy and favourable risk-benefit ratio when the anti-PD-1 monoclonal antibody is added to standard-of-care (SoC) chemotherapy as first-line (1L) treatment for previously untreated, inoperable, locally recurrent/metastatic squamous cell carcinoma of the anal canal (SCAC).

New drug applications approved by US FDA as of 1-15 September 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A closer look at antibiotic prescribing practices for childhood illnesses in Singapore uncovers opportunities for improvement, even when overall rates seem appropriate.

Metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD) may predispose affected individuals to liver and gastrointestinal cancers, as reported in a study.

Cannabinoids for medical purposes in children and adolescents have been linked to increased risk of adverse events (AEs), according to the results of a meta-analysis.

Disorders of gut-brain interaction during childhood may continue until adulthood in some patients, reveals a study, noting that management monitoring should persist into adulthood.